Hyperexpression of mitogen-activated protein kinase in human breast cancer.
暂无分享,去创建一个
[1] E. Goldsmith,et al. How MAP Kinases Are Regulated (*) , 1995, The Journal of Biological Chemistry.
[2] G. Nuovo,et al. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. , 1995, Cancer research.
[3] A. Brunet,et al. [MAP kinase module: role in the control of cell proliferation]. , 1995, Comptes rendus des seances de la Societe de biologie et de ses filiales.
[4] P. Wingo,et al. Cancer statistics, 1995 , 1995, CA: a cancer journal for clinicians.
[5] A. deFazio,et al. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. , 1994, Oncogene.
[6] G. Nuovo. PCR in situ hybridization. , 1994, Methods in molecular biology.
[7] A. Brunet,et al. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. , 1994, Oncogene.
[8] G. Nuovo,et al. PCR in situ hybridization. , 1994, Methods in molecular biology.
[9] Jane A. Langdale,et al. In situ Hybridization , 1994 .
[10] G. Nuovo,et al. In situ detection of PCR-amplified HIV-1 nucleic acids and tumor necrosis factor cDNA in cervical tissues. , 1993, The American journal of pathology.
[11] J. Blenis,et al. Signal transduction via the MAP kinases: proceed at your own RSK. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[12] C. Malbon,et al. Agonist Regulation of Gene Expression of Adrenergic Receptors and G Proteins , 1993, Journal of neurochemistry.
[13] L. Heasley,et al. MAP kinase is constitutively activated in gip2 and src transformed rat 1a fibroblasts. , 1992, The Journal of biological chemistry.
[14] D. Salomon,et al. Tyrosine kinase receptor--nuclear protooncogene interactions in breast cancer. , 1992, Cancer treatment and research.
[15] Mahlon D. Johnson,et al. Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[16] H. Brandwein,et al. Mammalian beta 1- and beta 2-adrenergic receptors. Immunological and structural comparisons. , 1986, The Journal of biological chemistry.